fda compounding semaglutide enforcement october 2025 news New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages Compounded weight-loss and hormone drugs

A meta-analysis of seven studies including 1,757 participants with type 2 diabetes found that SGLT2 inhibitor therapy in combination with blood pressure medications (known as renin-angiotensin system blockers) was well-tolerated and resulted in greater improvement in blood pressure, glucose control, body weight, and indices of kidney function compared with the blood pressure drugs alone (Tian 2021)

This configuration improved -cell engraftment and promoted glucose homeostasis in autoimmune diabetes models, demonstrating potential for enhancing regenerative therapies in metabolic disorders [200]

Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle

Avoid swallowing